Company Filing History:

19 out of 1,168

Glaxo Group Limited

Allen Hanburys Limited

patents

4. 1 out of 54

Biota Scientific Management Pty Ltd

patents

Years Active: 1980-2009

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7528148 - Pyrazolo[3,4-B]pyridine compounds, and their use as phosphodiesterase inhibitors (2009-05-05),

2. 7157494 - Dimeric compounds and their use as anti-viral agents (2007-01-02),

3. 6228853 - Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase (2001-05-08),

4. 6215002 - Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase (2001-04-10),

5. 6177425 - Pyrrolopyrrolone derivatives (2001-01-23),

6. 6057457 - Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase (2000-05-02),

7. 5994344 - Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase (1999-11-30),

8. 5498722 - Benzofuran derivatives (1996-03-12),

9. 5374646 - Benzofuran derivatives (1994-12-20),

10. 5332831 - Benzofuran derivatives (1994-07-26),

11. 5317023 - Benzofuran derivatives (1994-05-31),

12. 5310927 - Benzofuran derivatives (1994-05-10),

13. 5252593 - Pyrazole containing benzofuran derivatives and pharmaceutical (1993-10-12),

14. 5023378 - Amine derivatives (1991-06-11),

15. 4994483 - 5-substituted-3-aminoalkyl indole derivatives for migraine (1991-02-19),

Title: Michael D Dowle: Innovator in Pharmaceutical Compounds

Introduction: Michael D Dowle, based in Ware, GB, is a prolific inventor with a remarkable portfolio of 26 patents. His work primarily focuses on innovative pharmaceutical compounds that serve as crucial therapeutic agents in treating various diseases.

Latest Patents: Among his latest contributions to the field are notable patents related to Pyrazolo[3,4-B]pyridine compounds, which function as phosphodiesterase (PDE) inhibitors. These compounds are specifically useful in treating inflammatory and allergic conditions such as chronic obstructive pulmonary disease (COPD), asthma, and allergic rhinitis. Another significant patent involves dimeric compounds designed as anti-viral agents, emphasizing their potential in combating viral infections.

Career Highlights: Throughout his career, Michael D Dowle has been affiliated with reputable organizations including Glaxo Group Limited and Glaxo Wellcome Inc. His expertise and innovative approaches have led to the development of essential pharmaceutical products that address various health challenges.

Collaborations: Collaboration has played a vital role in Dowle's career. He has worked alongside distinguished colleagues such as Ian H Coates and David E Bays, contributing to the advancement of new therapeutic agents through combined knowledge and expertise.

Conclusion: Michael D Dowle has made significant strides in the world of pharmaceuticals through his innovative inventions and patents. His dedication is evident in his numerous contributions that aim to improve health outcomes and address pressing medical needs.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.